ReNeuron Group Quote more Price: 2.90 Chg: 0.12 Chg %: 3.97% Date: 16:52 Stem cell treatment developer ReNeuron lost an increased 7.1m in a "transformational" year to end-March but still had plenty of cash in the bank as it moves into new cell manufacturing facility and files an investigational new drug (IND) application in the US early next year. The AIM-listed company held cash outflow from operating activities roughly flat at 6m over the period, leaving cash, cash equivalents and bank deposits at period end of 20.92m, thanks to the 23.44m net fundraising in August 2013. Chairman Bryan Morton said it was a transformational year for the business, both operationally and financially, as its lead stem cell therapy candidate for stroke entered Phase II clinical trials and the company began clinical development of a candidate for critical limb ischaemia. He also noted that in both cases, and earlier-than-planned, ReNeuron gained regulatory approval to use a cryopreserved variant of its lead 'CTX' stem cell product line, which gives the treatments the potential to have "significant commercial and competitive advantages". He confirmed the move to new cell manufacturing facility in South Wales early next year was on track, "which we believe will … Continue reading →

KANSAS CITY, KS (KCTV) - A KCK company is developing a stem cell treatment to help dogs deal with crippling pain from arthritis. Aratana Therapeutics is working to treat osteoarthritis in pets via the stem cell treatment. If the U.S. Food and Drug Administration approves, it would be the first treatment of its kind. The treatment wouldn't provide a cure but would give much-needed relief. "They're still able to move better but they can't do the things they did when they were younger," dog owner Rachel Thieme said. Osteoarthritis can be quite debilitating for canines. "It's really tough because may be there are other areas of quality of life that are fine. They are eating fine. They have that motivation but they just can't physically do anything, so sometimes you have to euthanize them," Thieme said. The only way to cure the condition is to conduct a total joint replacement. But the stem cell procedure hopefully will reduce the need for medications and therapies, said Kara Forsee, a veterinary surgeon for BluePearl Veterinary Partners. See original here: KC area company developing stem cell treatments for pooches … Continue reading →

Beverly Hills, CA (PRWEB) June 16, 2014 The top stem cell doctors at Beverly Hills Orthopedic Institute are now offering regenerative medicine procedures for Achilles tendonitis and tears. The procedures include options for several types of stem cell procedures that can provide pain relief and help patients avoid surgery. Call (310) 438-5343 for more information and scheduling. Achilles tendonitis or tears may bother patients for many months and not respond well to traditional treatments. This may include NSAIDS, bracing and steroid injections. While surgery for these conditions may be extremely successful, there is often a considerable rehabilitation and potential surgery complications. Stem cell injections for Achilles tears or tendonitis have been a revolutionary treatment. This may include bone marrow derived injections, or amniotic derived stem cell procedures. Both offer exceptional concentrations of stem cells, growth factors and additional reparative materials. The procedures are performed as an outpatient, with the amniotic derived material coming from consenting donors after scheduled c-sections. There is no fetal material used, negating any ethical concerns. Dr. Raj at Beverly Hills Orthopedic Institute is a Double Board Certified orthopedic doctor. He treats patients from weekend warriors to amateur and professional athletes, along with celebrities, executives, manual laborers … Continue reading →